Education
About Us
Working with TipRanks
Follow Us
Peter Grua Insider Profile
4 Followers
Peter Grua, Director at Welltower, holds 60.67K shares in Evolent Health (Ticker: EVH), holds 0.00 shares in The Advisory Board (Ticker: ABCO), holds 29.27K shares in Welltower (Ticker: WELL). Most recently, Peter Grua Bought ― shares of Evolent Health on Mar 10, 2025 for an estimated value of 99.47K.
Peter Grua has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
The Advisory Board
(ABCO)
(ABCO)
Rating:Informative Sell
Date:Aug 18, 2016 - Aug 18, 2017
Return:-24.60%
The most profitable trade made by Peter Grua
Peter Grua's Trading History
Welltower
Mar 11, 2015
Director
Uninformative Sell
―
$4.32M
Evolent Health
Mar 10, 2025
Director
Informative Buy
99.47K
$545.41K
The Advisory Board
Nov 21, 2017
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Peter Grua's performance on stock
You May Also Like
Peter Grua insider profile FAQ
What is the percentage of profitable transactions made by Peter Grua?
The percentage of profitable transactions made by Peter Grua is ―.
What is the average return per transaction made by Peter Grua?
The average return per transaction made by Peter Grua is ―.
What stocks does Peter Grua hold?
Peter Grua holds: WELL, EVH, ABCO stocks.
What was Peter Grua’s latest transaction?
Peter Grua latest transaction was an Informative Buy of $99.47K.
What was Peter Grua's most profitable transaction?
Peter Grua’s most profitable transaction was an Informative Sell of ABCO stock on August 18, 2016. The return on the trade was -24.60%.
What is Peter Grua's role in Welltower?
Peter Grua's role in Welltower is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.